KEAP1 and metabolic dysfunction-associated steatotic liver disease: In this context, the study of the Nrf2/Keap1 pathway is particularly relevant, given the high prevalence of NAFLD in the general population, and in particular in those affected by type 2 diabetes and obesity (approximately 30%) [25].